These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16895961)

  • 1. 99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer.
    Rodrigues M; Li S; Gabriel M; Heute D; Greifeneder M; Virgolini I
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3997-4000. PubMed ID: 16895961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for sandostatin treatment in patients with progressive thyroid cancer and iodine-negative but somatostatin-receptor-positive metastases?
    Kohlfuerst S; Igerc I; Gallowitsch HJ; Gomez I; Kresnik E; Matschnig S; Lind P
    Thyroid; 2006 Nov; 16(11):1113-9. PubMed ID: 17123338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m depreotide imaging of I-131-negative recurrent metastatic papillary thyroid carcinoma.
    Valsamaki P; Gotzamani-Psarrakou A; Tsiouris S; Molyvda-Athanasopoulou E; Psarrakos K; Papantoniou V; Gerali S; Zerva C
    Int J Cancer; 2006 Aug; 119(4):968-70. PubMed ID: 16550594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
    Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
    J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
    Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
    Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of technetium-99m-labeled octreotide scintigraphy in local recurrent or metastatic medullary thyroid cancers: a comparison of lesions with 18F-FDG-PET and MIBI images.
    Sager S; Kabasakal L; Ocak M; Maecke H; Uslu L; Halaç M; Asa S; Sager G; Önsel Ç; Kanmaz B
    Nucl Med Commun; 2013 Dec; 34(12):1190-5. PubMed ID: 24121313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-EDDA/HYNIC-TOC and (18)F-FDG in thyroid cancer patients with negative (131)I whole-body scans.
    Gabriel M; Froehlich F; Decristoforo C; Ensinger C; Donnemiller E; von Guggenberg E; Heute D; Moncayo R
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):330-41. PubMed ID: 14625664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
    Halley A; Hugentobler A; Icard P; Porret E; Sobrio F; Lerochais JP; Bouvard G; Zalcman G; Agostini D
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1026-32. PubMed ID: 15877227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
    Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer.
    Kahn D; Menda Y; Kernstine K; Bushnell D; McLaughlin K; Miller S; Berbaum K
    Chest; 2004 Feb; 125(2):494-501. PubMed ID: 14769730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology.
    Piccardo A; Puntoni M; Treglia G; Foppiani L; Bertagna F; Paparo F; Massollo M; Dib B; Paone G; Arlandini A; Catrambone U; Casazza S; Pastorino A; Cabria M; Giovanella L
    Eur J Endocrinol; 2016 May; 174(5):693-703. PubMed ID: 26966173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of positron emission tomography with [(18)F]FDG and [(68)Ga]DOTATOC in recurrent differentiated thyroid cancer: preliminary data.
    Middendorp M; Selkinski I; Happel C; Kranert WT; Grünwald F
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):76-83. PubMed ID: 20168289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma.
    Chen YK; Liu FY; Yen RF; Kao CH
    Acad Radiol; 2003 Aug; 10(8):835-9. PubMed ID: 12945916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
    Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N
    J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of
    Wu D; Ylli D; Gomes Lima CJ; Lee W; Burman KD; Wartofsky L; Van Nostrand D
    Endocrine; 2018 Oct; 62(1):57-63. PubMed ID: 29797211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.